Zobrazeno 1 - 10
of 2 624
pro vyhledávání: '"Vargaftig Bb"'
Publikováno v:
Memorias do Instituto Oswaldo Cruz, Vol 92, Iss suppl.2, Pp 109-114 (1997)
In this review we discuss our recently results showing interleukin 5 (IL-5) involvement in eosinophil migration and in the maintenance of eosinophilia in blood, bone marrow, lung and peritoneal cavity, in a visceral larva migrans syndrome model using
Externí odkaz:
https://doaj.org/article/174e0c25010b4ad296a3eee1e7b18bc0
Autor:
Breithaupt-Faloppa AC, Fantozzi ET, de Assis Ramos MM, Vitoretti LB, Couto GK, Lino-dos-Santos-Franco A, Rossoni LV, Oliveira-Filho RM, Vargaftig BB, Tavares-de-Lima W
Publikováno v:
Shock (Augusta, Ga.) [Shock] 2013 Sep; Vol. 40 (3), pp. 203-9.
Autor:
Vargaftig BB
Publikováno v:
Agents and actions [Agents Actions] 1994 Dec; Vol. 43 (3-4), pp. 158-66; discussion 167.
Autor:
Ricardo-da-Silva FY; Laboratorio de Cirurgia Cardiovascular e Fisiopatologia da Circulacao (LIM-11), Instituto do Coracao (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, BR., Fantozzi ET; Departamento de Farmacologia, Instituto de Ciencias Biomedicas, Universidade de Sao Paulo, Sao Paulo, SP, BR., Rodrigues-Garbin S; Departamento de Farmacologia, Instituto de Ciencias Biomedicas, Universidade de Sao Paulo, Sao Paulo, SP, BR., Domingos HV; Departamento de Farmacologia, Instituto de Ciencias Biomedicas, Universidade de Sao Paulo, Sao Paulo, SP, BR., Oliveira-Filho RM; Departamento de Farmacologia, Instituto de Ciencias Biomedicas, Universidade de Sao Paulo, Sao Paulo, SP, BR., Vargaftig BB; Departamento de Farmacologia, Instituto de Ciencias Biomedicas, Universidade de Sao Paulo, Sao Paulo, SP, BR., Riffo-Vasquez Y; Sackler Institute of Pulmonary Pharmacology, Institute of Pharmaceutical Science, King's College London, London, UK., Breithaupt-Faloppa AC; Laboratorio de Cirurgia Cardiovascular e Fisiopatologia da Circulacao (LIM-11), Instituto do Coracao (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, BR., Tavares-de-Lima W; Departamento de Farmacologia, Instituto de Ciencias Biomedicas, Universidade de Sao Paulo, Sao Paulo, SP, BR.
Publikováno v:
Clinics (Sao Paulo, Brazil) [Clinics (Sao Paulo)] 2021 Apr 26; Vol. 76, pp. e2683. Date of Electronic Publication: 2021 Apr 26 (Print Publication: 2021).
Autor:
Lepage, Tristan M.1,2 (AUTHOR), Nzune-Toche, Narcisse3 (AUTHOR), Nkwengoua, Lucie A.4 (AUTHOR), Nana-Djeunga, Hugues C.3 (AUTHOR), Pion, Sebastien D. S.2 (AUTHOR), Kamgno, Joseph3,4 (AUTHOR), Boullé, Charlotte1,2 (AUTHOR), Campillo, Jérémy T.2 (AUTHOR), Boussinesq, Michel2 (AUTHOR), Tayou, Claude T.4,5 (AUTHOR), Chesnais, Cédric B.2 (AUTHOR) cedric.chesnais@ird.fr
Publikováno v:
PLoS Neglected Tropical Diseases. 12/16/2024, Vol. 18 Issue 12, p1-9. 9p.
Autor:
Deng, Yuqing1 (AUTHOR), Herrmann, Jacob2,3 (AUTHOR), Wang, Yu3 (AUTHOR), Nguyen, Minh3 (AUTHOR), Hall, Joseph K.3 (AUTHOR), Kim, Jae Hun3 (AUTHOR), Smith, Michael L.3 (AUTHOR), Lutchen, Kenneth R.3 (AUTHOR), Bartolák-Suki, Elizabeth3 (AUTHOR), Suki, Béla3 (AUTHOR) bsuki@bu.edu
Publikováno v:
Scientific Reports. 11/22/2024, Vol. 14 Issue 1, p1-14. 14p.
Publikováno v:
Current drug targets. Inflammation and allergy. 2(4)
We used a variety of techniques to evaluate the effects of airway allergen exposure in mice on the responses of hemopoietic cells to cytokines and drugs in vitro and in vivo. Initial studies have shown that allergen exposure of sensitized mice leads
Autor:
Hans, Sakshi1,2 (AUTHOR), Stanton, Janelle E.1,2 (AUTHOR), Sauer, Ann Katrin1,2,3 (AUTHOR), Shiels, Katie4 (AUTHOR), Saha, Sushanta Kumar4 (AUTHOR), Lordan, Ronan5,6,7 (AUTHOR), Tsoupras, Alexandros8 (AUTHOR), Zabetakis, Ioannis1,2,3 (AUTHOR), Grabrucker, Andreas M.1,2,3 (AUTHOR) andreas.grabrucker@ul.ie
Publikováno v:
Lipids in Health & Disease. 4/20/2024, Vol. 23 Issue 1, p1-15. 15p.
Publikováno v:
Mediators in Airway Hyperreactivity ISBN: 9783034873819
The booster injection of antigen to pre-sensitized guinea-pigs induces lung modifications leading to hyperresponsiveness and to shifts in the profile of the effective drugs. The introduction of the concept of lung inflammation offers new targets for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8988c996905ad0a87fa4c3cfc64a01be
https://doi.org/10.1007/978-3-0348-7379-6_2
https://doi.org/10.1007/978-3-0348-7379-6_2
Autor:
Ricardo-da-Silva FY; Laboratory of Cardiovascular Surgery and Circulation Pathophysiology (LIM-11), Heart Institute (InCor), Medical School, São Paulo, Brazil †Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil., Fantozzi ET, Rodrigues-Garbin S, Oliveira-Filho RM, Vargaftig BB, Breithaupt-Faloppa AC, Tavares de Lima W
Publikováno v:
Shock (Augusta, Ga.) [Shock] 2017 Oct; Vol. 48 (4), pp. 477-483.